Publication | Open Access
Andrographolide in atherosclerosis: integrating network pharmacology and <i>in vitro</i> pharmacological evaluation
18
Citations
47
References
2022
Year
We successfully predict AG's potential targets and pathways in atherosclerosis and illustrate the mechanism of action. AG may regulate NF-κB/CEBPB/PPARG signaling to alleviate atherosclerosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1